Intermittent claudication as a manifestation of silent myocardial ischemia: a pilot study
A M Salmasi1, A Nicolaides, A Al-Katoubi
1Vascular Section, Irvine Laboratory for Cardiovascular Investigation and Research, St. Mary's Hospital Medical School, London, United Kingdom.
Insights
Silent myocardial ischemia is common in patients with intermittent claudication, causing cardiac dysfunction and early exercise limitation. Treatments like myocardial revascularization improve cardiac function and walking ability.
Area of Science:
- Cardiology
- Vascular Medicine
- Exercise Physiology
Background:
- Intermittent claudication (IC) is a common symptom of peripheral artery disease.
- Silent myocardial ischemia (SMI) may coexist and impact exercise capacity.
- Noninvasive screening for SMI in IC patients is valuable.
Purpose of the Study:
- To investigate the prevalence and impact of SMI in patients with IC.
- To assess the effect of interventions on cardiac function and exercise tolerance.
Main Methods:
- 100 IC patients underwent electrocardiography chest wall mapping stress tests and transcutaneous aortovelography.
- Coronary angiography confirmed findings in 32 patients with identified coronary artery disease.
- Evaluated changes after myocardial revascularization or medical therapy.
Main Results:
- SMI was detected in 32% of patients, correlating with reduced stroke distance (cardiac stroke volume).
- Interventions led to significant improvements in post-exercise stroke distance and recovery time.
- Claudication distance improved significantly in treated patients.
Conclusions:
- SMI is prevalent in IC patients, contributing to left ventricular dysfunction and early claudication.
- Myocardial revascularization and medical therapy can improve cardiac function and exercise capacity.
- Noninvasive screening for SMI is crucial in managing IC patients.
Abstract:
One hundred consecutive patients with intermittent claudication were screened noninvasively with electrocardiography chest wall mapping stress test and transcutaneous aortovelography during bicycle ergometry. Electrocardiographic chest wall stress testing indicated three-vessel coronary disease in 25 patients and left anterior descending plus circumflex (left main stem equivalent) disease in seven. In these 32 patients transcutaneous aortovelography demonstrated a decrease in stroke distance (an index of cardiac stroke volume) (median, -28%; 90% range, +5% to -48%), and coronary angiography confirmed the presence and severity of the disease. The claudication distance ranged between 50 and 250 meters. After myocardial revascularization or medical therapy a significant increase occurred in the stroke distance after exercise (median, +20; 90% range, +40% to -25%); also a significant increase in the postexercise pressure index and a reduction in the recovery time (p less than 0.01). No change occurred in the ankle/pressure index at rest. Twelve patients were able to walk without being limited by claudication; 15 reported improvement with a two to tenfold increase in claudication distance. No change occurred in three. The results indicate that silent myocardial ischemia is a common finding in patients with intermittent claudication. It produces left ventricular dysfunction and a decrease in stroke volume leading to a large fall in ankle pressure and early onset of claudication during exercise. Niltrates and myocardial revascularization tend to reverse this.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation


